SUVN-502#39;s clinical trial data assumed significance as no new Alzheimer#39;s drug has been approved since Forest Labs#39; Namenda in 2003from Moneycontrol Business News https://ift.tt/2DDy6ny
Sunday, December 1, 2019
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment